StreetAlpha.app
Home › Stocks › ENOV

Enovis CORP (ENOV)

Industrials
$27.21
▼ −2.65%
LAST CLOSE · NOV 17

Enovis makes medical devices for injury prevention, rehabilitation and joint reconstruction, sold to surgeons, clinicians and consumers. It last closed at $27.21 on Nov 17, down 2.65% on the day. The average 12-month price target from 7 analysts is $39.29 (+44.4% from the last close), with a high of $47.00 and a low of $33.00. Analyst consensus is Strong Buy, based on the latest ratings from 7 firms (7 buy, 0 hold, 0 sell).

AI Auto Pilots
Is ENOV in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.3B
+3.3% vs a year ago
Net income
−$527.4M
−22.9% margin
EPS (diluted)
−$9.23
Free cash flow
$69.6M
3.0% margin
Valuation
Market cap
$1.6B
57.7M shares
P/E
–
No P/E while losing money
Price to sales
0.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$13.0M
At Oct 2
Debt
$1.3B
At Oct 2
Shareholder equity
$1.5B
Shares outstanding
57.7M
At Oct 30
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $1.4B$1.4BFY2021FY2022: $1.6B$1.6BFY2022FY2023: $1.7B$1.7BFY2023FY2024: $2.1B$2.1BFY2024FY2025: $2.2B$2.2BFY2025

From ENOV's SEC filings, latest 10-Q for the period ending Oct 2, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 7 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
7firms
7 Buy0 Hold0 Sell
Each firm's latest rating on ENOV in the past 90 days
Average 12-month target
$39.29
▲ 44.4% upside

Based on 7 analysts who set a price target on ENOV in the past 90 days. The average target is $39.29, with a high of $47.00 and a low of $33.00, compared with the last close of $27.21.

Low $33.00Avg $39.29High $47.00
Blue marker: last close $27.21
Highest target$47.00
Average target$39.29
Lowest target$33.00
Latest rating changes
Canaccord GenuityTarget lowered
Nov 6Buy$45 → $42
Evercore ISI GroupTarget raised
Nov 6Buy$32 → $33
Wells FargoTarget raised
Nov 6Buy$33 → $37
NeedhamTarget raised
Nov 5Buy$34 → $38
BTIGTarget raised
Nov 5Buy$36 → $42
DateFirmActionRatingPrice target
Nov 6Canaccord GenuityTarget loweredBuy$45 → $42
Nov 6Evercore ISI GroupTarget raisedBuy$32 → $33
Nov 6Wells FargoTarget raisedBuy$33 → $37
Nov 5NeedhamTarget raisedBuy$34 → $38
Nov 5BTIGTarget raisedBuy$36 → $42
Loading…

Technical Analysis

ENOV · as of the Nov 17 close · updated after every close
Turning up, nearing overbought

The stock is 10% above its 20 day and 23% above its 50 day average. It is 14% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 63), near overbought. The nearest support is the Pivot S1 at $26.85, and the nearest resistance the swing high (Aug 19) at $27.46.

Short trendBullish
Long trendNeutral
MomentumStrong
StretchNear overbought
VolatilityHigh, 5.4%/day
Key levels
$31.6752 week high+16.4%
$27.92Pivot R1+2.6%
$27.56Pivot+1.3%
$27.46Swing high (Aug 19)+0.9%
$27.21Last close
$26.85Pivot S1−1.3%
$25.40Swing low (Jul 23)−6.7%
$24.4220 day average−10.3%
$23.29200 day average−14.4%
$23.15100 day average−14.9%
$20.8650 day average−23.3%
$16.7052 week low−38.6%
Indicators
RSI (14)63.27Strong, overbought above 70Neutral
MACD2.14Above its signal lineBullish
Stochastic77.3Middle of its rangeNeutral
ADX (14)42.7Strong uptrend
Williams %R-26.6Oversold below −80, overbought above −20Neutral
CCI (20)66.1Oversold below −100, overbought above 100Neutral
Rate of change+30.3%Change over 10 sessionsBullish
ATR (14)$1.47Typical daily range, 5.4% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ENOV

What happened before

See how ENOV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ENOV usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ENOV has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2008.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ENOV in the last 90 days.

Loading…

See today’s whale options flow across the market →

ENOV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼106 buying vs 152 selling
  • ▲Held by funds +11.1 pts
  • ▼Funds holding -8
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding249257−3.1%
In funds' top 1031+200.0%
Held by funds134.5%123.4%+11.1 pts
New / increased41 / 6542 / 88−18.5%
Reduced / sold out104 / 4888 / 46+13.4%
Put/call ratio0.000.04−100.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ENOV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ENOV is in one of them and how their past ENOV trades turned out.

ENOV in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ENOV in an article yet. Here's the latest on the wider market.

ENOV Congress Trades

All congress trades →
Trades, 12 months
2
Buys
1
50%
Sells
0
0%
People
1
Last filed May 14
Who traded ENOV · since 2026
Latest 2 filings
$15K – $50KTraded Feb 26, 2026Filed May 14, 2026
$15K – $50KTraded Jan 26, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchBuy$15K – $50KFeb 26, 2026May 14, 202677 d
Donald J TrumpExecutive branchOther$15K – $50KJan 26, 2026May 14, 2026108 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Enovis

Enovis is a medical technology company based in Lewisville, Texas. It makes medical devices in two main areas. One covers braces, compression garments, bone growth stimulators and therapy products used for injury prevention and rehabilitation. The other covers implants and surgical instruments for joint replacement, limb reconstruction and foot and ankle procedures. Its customers include orthopedic surgeons, physical therapists, other healthcare professionals, healthcare systems, athletes and retail consumers.

Headquarters
Lewisville, TX